Optical Imaging for Gum Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test a new optical imaging method for examining the mechanical properties of tissues, which can aid in understanding conditions like gum disease and keratoconus (a condition where the cornea thins and bulges). Researchers will use optical imaging on both healthy tissues, such as the cornea, skin, and gums, and on corneas affected by mild or moderate keratoconus. Individuals with mild or moderate keratoconus or healthy individuals without eye or skin issues might be suitable for this study. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could lead to better diagnostic tools.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that optical imaging of tissues is safe?
Research has shown that optical imaging, particularly Optical Coherence Tomography (OCT), is generally safe for people. OCT is non-invasive, meaning it doesn't require cuts or harmful substances. Studies have demonstrated that it can produce clear images of tissues without causing harm.
In previous studies, OCT was used on various tissues, such as the gums and eyes, without any reports of serious side effects. These results suggest that the technique is well-tolerated. Whether used on healthy skin, gums, or eyes with keratoconus (a condition affecting the cornea), OCT has consistently been safe in research settings.12345Why are researchers excited about this trial?
Researchers are excited about optical imaging for gum disease because it offers a non-invasive way to examine tissues, which is different from traditional methods like probing or X-rays. This technique provides real-time, high-resolution images, allowing for early detection of gum issues without discomfort. By targeting the condition with precision, optical imaging has the potential to improve diagnosis and monitoring, making dental care more proactive and personalized.
What evidence suggests that optical imaging is effective for gum disease?
Research has shown that Optical Coherence Tomography (OCT) effectively captures detailed images of gum tissues. This non-invasive method, which requires no surgery or cutting, provides clear, real-time images that aid in diagnosing gum disease. Studies have found that OCT accurately assesses both soft and hard tissues, making it useful for identifying issues in the gums and other areas. Additionally, OCT is a preferred choice for diagnosing various oral conditions due to its detailed imaging. In this trial, participants will undergo optical imaging of the gingiva to explore its potential in assessing gum health and detecting gum disease.13456
Who Is on the Research Team?
Seok-Hyun Yun, PhD
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
This trial is for people aged 18-75 with healthy eyes. It's designed to test a new imaging technique on various tissues, including gums, skin, and corneas.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Imaging
Optical imaging of the cornea, skin, and gingiva in healthy subjects and cornea in keratoconus subjects
Follow-up
Participants are monitored for safety and effectiveness after imaging procedures
What Are the Treatments Tested in This Trial?
Interventions
- Optical imaging of the tissues
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
Massachusetts Eye and Ear Infirmary
Collaborator